NewsPronto

 
Times Advertising


.

ACN Newswire

Read more press releases from ACN Newswire here

Aptorum Group Announces Further Positive Data for its ALS-4 Small Molecule Anti-virulence (Non-bactericidal) Drug Candidate

  • Written by ACN Newswire

image

HONG KONG, Feb 11, 2020 - (ACN Newswire) - Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces further positive data from its current investigational new drug (IND)-enabling studies for ALS-4, a small drug molecule...

Read more: Aptorum Group Announces Further Positive Data for its ALS-4 Small Molecule Anti-virulence...